MedTrace Logo

THP Hip Fracture Plating System Study

NCT03870477 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2022-05-12

Study results available
· View outcomes & findings →

Summary

The objective of this study is to systematically document the clinical outcomes of THP Hip Fracture Plating System when used to treat intracapsular and intertrochanteric fractures.

Conditions

  • Femur Fracture
  • Femur Fracture Intertrochanteric
  • Garden Grade I Subcapital Fracture of Femoral Neck
  • Garden Grade II Subcapital Fracture of Femoral Neck
  • Garden Grade III Subcapital Fracture of Femoral Neck
  • Garden Grade IV Subcapital Fracture of Femoral Neck

Interventions

DEVICE

THP Hip Fracture Plating System with telescoping lag screws

The fracture plates are contoured plates used in conjunction with telescoping lag screws that are 7.5mm in diameter with lengths ranging from 70mm to 130mm in 5mm increments.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Ryan Boylan, MBA · Zimmer Biomet

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-16
Primary Completion
2021-03-10
Completion
2021-03-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870477 on ClinicalTrials.gov